Cargando…
Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality. Prognostic biomarkers to identify rapid progressors are urgently needed to improve patient management. Since the lysophosphatidic acid (LPA) pathway has been implicated in lung fibrosis in preclinical models and...
Autores principales: | Neighbors, Margaret, Li, Qingling, Zhu, Sha (Joe), Liu, Jia, Wong, Weng Ruh, Jia, Guiquan, Sandoval, Wendy, Tew, Gaik W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205439/ https://www.ncbi.nlm.nih.gov/pubmed/37075981 http://dx.doi.org/10.1016/j.jlr.2023.100375 |
Ejemplares similares
-
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
por: Stephenson, Daniel J., et al.
Publicado: (2023) -
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
por: Li, Qingling, et al.
Publicado: (2021) -
Accumulation of saturated intramyocellular lipid is associated with insulin resistance
por: Savage, David B., et al.
Publicado: (2019) -
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study
por: Thomas, David G., et al.
Publicado: (2021) -
Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis
por: Gaspar, Paulo, et al.
Publicado: (2014)